These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36072794)

  • 1. Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():979968. PubMed ID: 36072794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():632042. PubMed ID: 35515103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():801970. PubMed ID: 34900749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBC1D3 family is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma.
    Wang B; Chen D; Hua H
    Mol Ther Oncolytics; 2021 Sep; 22():528-538. PubMed ID: 34553038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
    Zhang K; Liu H; Yu M; Zhao H; Yang N; Bi X; Sun L; Lin R; Lü G
    Front Oncol; 2021; 11():785394. PubMed ID: 34722323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.
    Han C; Chen J; Huang J; Zhu R; Zeng J; Yu H; He Z
    Front Oncol; 2023; 13():1162375. PubMed ID: 36969048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Hu X; Bao M; Huang J; Zhou L; Zheng S
    Front Oncol; 2020; 10():617539. PubMed ID: 33330112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
    Front Oncol; 2023; 13():1134139. PubMed ID: 37025598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
    Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J
    Front Oncol; 2021; 11():843623. PubMed ID: 35111689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIF4A is a promising prognostic marker and correlates with immune infiltration in clear cell renal cell carcinoma.
    Li C; Chen J; Su Z
    Transl Cancer Res; 2020 Nov; 9(11):7165-7173. PubMed ID: 35117320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Yao Y; Wang Y; Wu D; Hu B
    Front Oncol; 2021; 11():731942. PubMed ID: 34368004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.
    Chen Q; Tan Y; Zhang C; Zhang Z; Pan S; An W; Xu H
    Front Oncol; 2021; 11():683333. PubMed ID: 33937088
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
    Che L; Paliogiannis P; Cigliano A; Pilo MG; Chen X; Calvisi DF
    Front Oncol; 2022; 12():874053. PubMed ID: 35494002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma.
    Song Q; Zheng Y; Wu J; Wang S; Meng L; Yao Q; Li Z; Lian S
    Front Immunol; 2021; 12():717688. PubMed ID: 34630392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis
    Wen J; Aili A; Yan YX; Lai Y; Niu S; He S; Zhang X; Zhang G; Li J
    Front Oncol; 2022; 12():1038279. PubMed ID: 36387066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of TRPV family to prognosis and immune infiltration in renal clear cell carcinoma.
    Gong Z; Xie J; Chen L; Tang Q; Hu Y; Xu A; Wang Z
    Channels (Austin); 2022 Dec; 16(1):84-96. PubMed ID: 35389815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.